Daniella Kranjac
Solo GP · New York, NY
Daniella Kranjac is a solo GP based in New York, NY focused on Biotech & Pharma, investing at pre-seed to series b stage. Daniella Kranjac's most recent fund with a disclosed size, Avant Bio Fund II LP, filed a $57.5M offering with the SEC in Dec 2024. Estimated typical check: $575K–$1.7M. Daniella Kranjac's latest dated investing activity was in Dec 2024.
Why Daniella Kranjac is listed
Named as the only individual (director) on the Form D for Avant Bio Fund II LP, a $57.5M venture fund (Dec 2024). Also a non-executive director at 3 startups that filed Form D.
Source: SEC Form D: Avant Bio Fund II LP (Dec 23, 2024) · 3 more sources
Is this you? Remove or correct this profile.
- Stages
- Pre-seed to Series B
- Typical check (est.)
- $575K–$1.7M
- Latest fund
- $57.5M · Dec 2024
- Latest dated activity
- Dec 2024
Is Daniella Kranjac a fit for you?
See your fit score and the reason, contact details, and any warm path from your network.
What does Daniella Kranjac invest in?
Biotech & PharmaWhat has Daniella Kranjac invested in recently?
- Mar 2024
Alpenglow Biosciences
Board seat on the company's SEC filing (not by itself proof of an investment) · WA
- Jan 2024
Virica Biotech
Board seat on the company's SEC filing (not by itself proof of an investment) · A6
- Aug 2023
Avant Bio Fund II LP
Invested through a fund
- Jun 2023
Vernal Biosciences
Board seat on the company's SEC filing (not by itself proof of an investment) · VT
Funds and deal vehicles Daniella Kranjac filed with the SEC
- Dec 2024
Avant Bio Fund II LP
Fund · $57.5M offering
Sources
- SEC Form D: Avant Bio Fund II LPDec 23, 2024
- SEC Form D (board seat): Vernal BiosciencesJun 16, 2023
- SEC Form D (board seat): Virica BiotechJan 26, 2024
- SEC Form D (board seat): Alpenglow BiosciencesMar 25, 2024
Data refreshed from public sources Oct 15, 2026. Is this you? Remove or correct this profile.